ARDF Strategy
Fund
The ARDF
Annual Open Grant Program was established to fund research projects that develop alternative methods or utilize an alternative approach in research, testing or education. Over $4 million in grants have been awarded to date.
ARDF's new
Alternatives in Research (AiR) Challenge program will stimulate innovation in alternative methods, focused on biomedical research.
Promote
ARDF works to promote alternatives through the sponsorship of scientific meetings across the globe, participation in regulatory and industry meetings, and providing free consultations with media representatives, scientists, and government officials. ARDF also engages in legal advocacy to accelerate acceptance and utilization of alternative methods, such as its successful legal petitions to National Institutes of Health to require its grantees to produce monoclonal antibodies via
in vitro methods, as opposed to traditional mouse ascites.
Reward
Recognizing individuals in the scientific community who have made extraordinary contributions to the advancement of alternatives, ARDF rewards scientists through its
William and Eleanor Cave Award.
Leadership
Sue A. Leary | President
Sue A. Leary has been President and CEO of ARDF since 1995. She has a B.S. in Biology and M.S. in Nonprofit Management. Her career has focused on coordination of programs and services; education and advocacy; administration and planning; and membership development in nonprofit organizations. Since 1995, she has served as President of the Alternatives Research & Development Foundation (ARDF) and its affiliate, American Anti-Vivisection Society (AAVS). Ms. Leary is Executive Editor of the AV Magazine, and Chair of the Coalition for Consumer Information on Cosmetics (CCIC), which operates the Leaping Bunny Program. She has served on a number of boards, including the Global Federation of Animal Sanctuaries.
Angela N. Hvitved | Program Director
Dr. Hvitved manages ARDF’s grant application, review, and post-award activities, and helps to develop new programs and funding strategies. Prior to joining ARDF, she worked as a scientific review consultant, managing scientific review for clinical trial proposals.
Earlier in her career, Dr. Hvitved held positions in both policy and regulatory offices in the federal government. She served as a Public Health Advisor at the U.S. Department of Health and Human Services (HHS) Office for Human Research Protections (OHRP) and was a Health Science Policy Analyst at the National Institutes of Health (NIH), where she covered a broad range of policy areas. Dr. Hvitved received a PhD in Biochemistry and Cell Biology from Rice University and a PhD in Philosophy from Johns Hopkins University.
Board of Directors
Sue A. Leary |
President
Joseph Ludwig |
Vice President
Aaron McIntyre |
Treasurer
Denise Cowie |
Secretary
Nadia Adawi, Esq.
Robert Finn
Luke Klein
